Streetbeat News

Stock Prices

PRTG

Portage Biotech reported updated interim data from the Phase 1 trial for the treatment of advanced melanoma and metastatic non-small cell lung cancer at the 2023 ASCO Annual Meeting, leading to higher trading of its shares.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 3:39 pm

SYTA

Siyata Mobile announced receiving $400,000 in new orders for its SD7 Handsets and VK7 Vehicles Kits, leading to a higher trading of its shares.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 3:35 pm

SNOW

A whale investor has taken a bearish stance on Snowflake (NYSE:SNOW), with 54% of detected trades having bearish expectations. Whales have been targeting a price range of $172.5 to $200 for Snowflake over the last 3 months. Analysts have mixed price targets, ranging from $148 to $215.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 3:32 pm

MMM

A whale has taken a bearish stance on 3M (NYSE:MMM), with 61% of detected unusual options trades being bearish. Whales have been targeting a price range of $90 to $105 for 3M over the last 3 months. RBC Capital downgraded its action to Underperform with a price target of $95, while UBS maintained a Neutral rating with a price target of $95.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 3:31 pm

AMRS

CSTL

EPAM

U.S. stocks traded mixed on Monday, with several big stocks recording losses. Castle Biosciences, EPAM Systems, and Amyris were among the companies experiencing significant drops in share prices.

Portfolio Pulse from Lisa Levin

June 05, 2023 | 3:30 pm

AMD

Advanced Micro Devices (NASDAQ:AMD) has outperformed the market over the past 15 years, producing an average annual return of 20.3%. A $1000 investment in AMD 15 years ago would be worth $15,483.07 today.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 3:30 pm

ADI

Analog Devices (NASDAQ:ADI) has outperformed the market over the past 15 years, producing an average annual return of 11.59%. A $100 investment in ADI stock 15 years ago would be worth $507.50 today.

Portfolio Pulse from Benzinga Insights

June 05, 2023 | 3:30 pm

GILD

Gilead's Kite's Yescarta CAR T-cell therapy shows statistically significant overall survival (OS) for initial treatment of R/R LBCL, with a 27.4% reduction in risk of death and a 38% relative improvement in OS. The data was highlighted at ASCO 2023 and published in the New England Journal of Medicine.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 3:27 pm

MRVL

Marvell Technology shares are trading lower, possibly due to a pullback following recent momentum in semiconductor and chip stocks.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2023 | 3:26 pm

AMZN

Amazon has settled two privacy cases with the FTC related to Alexa and Ring, paying multi-million dollar fines. Despite these settlements, Amazon's stock price has not been affected and has recently risen by 3%.

Portfolio Pulse from Zaheer Anwari

June 05, 2023 | 3:26 pm